Carl Atkinson to Melanoma, Experimental
This is a "connection" page, showing publications Carl Atkinson has written about Melanoma, Experimental.
Connection Strength
0.153
-
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight. 2017 03 09; 2(5):e90772.
Score: 0.130
-
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood. 2012 Jun 21; 119(25):6043-51.
Score: 0.023